ORGO

Organogenesis Holdings Inc.

Biotechnology · Biotechnology

$80.42 sample

-0.15 (-0.19%) 1D

Market cap

$274.5B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-24

Alerts

8

Price$80.42 -5.18% 3M daily closessample

85.0177.57

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: 10% owner
Sep 16INSInsider sell: Director
Sep 07INSInsider sell: 10% owner
Aug 31INSInsider sell: General Counsel
Aug 24SECDEF 14A filed
Aug 18INSInsider sell: Chief Financial Officer
Aug 13INSInsider sell: EVP, Operations
Aug 04SECDEF 14A filed

Sign up to see the real ORGO record →

Company facts

SEC EDGAR registration

Name: Organogenesis Holdings Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in ORGO

sample

Insiders: 21 insider transactions over 90 days, net selling, $807.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 31 funds hold $6.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.6B +17.7% y/y

Q4 2024Q3 2026

Inventory$5.8B +13.6% y/y

Q4 2024Q3 2026

Accounts receivable$4.4B +16.7% y/y

Q4 2024Q3 2026

Total debt$11.6B +6.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $91.8B +15.9% 3M
Sample peer B: $188.2B -6.1% 3M
Sample peer C: $138.5B -1.8% 3M
Sample peer D: $105.4B -9.4% 3M
Sample peer E: $233.2B -8.5% 3M